330 related articles for article (PubMed ID: 12539026)
1. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
2. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
[TBL] [Abstract][Full Text] [Related]
3. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
[TBL] [Abstract][Full Text] [Related]
4. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
Epstein JB; Sciubba J; Silverman S; Sroussi HY
Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
[TBL] [Abstract][Full Text] [Related]
5. Advances in the diagnosis of oral premalignant and malignant lesions.
Epstein JB; Zhang L; Rosin M
J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of oral lichen planus. A premalignant lesion?
Zhang L; Michelsen C; Cheng X; Zeng T; Priddy R; Rosin MP
Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
[TBL] [Abstract][Full Text] [Related]
7. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.
Zhang L; Williams M; Poh CF; Laronde D; Epstein JB; Durham S; Nakamura H; Berean K; Hovan A; Le ND; Hislop G; Priddy R; Hay J; Lam WL; Rosin MP
Cancer Res; 2005 Sep; 65(17):8017-21. PubMed ID: 16140975
[TBL] [Abstract][Full Text] [Related]
8. Allelic imbalance on chromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa.
Guo T; Sun JW; Lv QP; Li XG
J Laryngol Otol; 2008 Jan; 122(1):72-7. PubMed ID: 17498326
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis.
Roz L; Wu CL; Porter S; Scully C; Speight P; Read A; Sloan P; Thakker N
Cancer Res; 1996 Mar; 56(6):1228-31. PubMed ID: 8640803
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
11. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx.
Tabor MP; Braakhuis BJ; van der Wal JE; van Diest PJ; Leemans CR; Brakenhoff RH; Kummer JA
J Pathol; 2003 Mar; 199(3):354-60. PubMed ID: 12579537
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
13. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
14. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions.
Zhou X; Jordan RC; Li Y; Huang BL; Wong DT
Cancer Genet Cytogenet; 2005 Aug; 161(1):86-9. PubMed ID: 16080964
[TBL] [Abstract][Full Text] [Related]
15. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
17. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma.
Kayahara H; Yamagata H; Tanioka H; Miki T; Hamakawa H
J Hum Genet; 2001; 46(6):335-41. PubMed ID: 11393537
[TBL] [Abstract][Full Text] [Related]
19. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions.
Shimada M; Yanagisawa A; Kato Y; Inoue M; Shiozaki H; Monden M; Nakamura Y
Genes Chromosomes Cancer; 1996 Mar; 15(3):165-9. PubMed ID: 8721680
[TBL] [Abstract][Full Text] [Related]
20. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
